[go: up one dir, main page]

CR9300A - Uso de compuestos de hierro (iii) - Google Patents

Uso de compuestos de hierro (iii)

Info

Publication number
CR9300A
CR9300A CR9300A CR9300A CR9300A CR 9300 A CR9300 A CR 9300A CR 9300 A CR9300 A CR 9300A CR 9300 A CR9300 A CR 9300A CR 9300 A CR9300 A CR 9300A
Authority
CR
Costa Rica
Prior art keywords
iii
iron compounds
iron
carbohydrates
medicament
Prior art date
Application number
CR9300A
Other languages
English (en)
Inventor
Tanner-Baum-Gartner Jessica
Chandra Ranjeet
Geisser Peter
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of CR9300A publication Critical patent/CR9300A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion presentada se refiere a nuevos usos terapeuticos con hiero (III)- uniones complejas con carbohidratos o sus derivados, para l acracion de un medicamento para el mejoramiento de la defensa inmune y/o rendimiento cerebral.
CR9300A 2005-02-09 2007-08-09 Uso de compuestos de hierro (iii) CR9300A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05100907 2005-02-09

Publications (1)

Publication Number Publication Date
CR9300A true CR9300A (es) 2007-12-07

Family

ID=34938674

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9300A CR9300A (es) 2005-02-09 2007-08-09 Uso de compuestos de hierro (iii)

Country Status (26)

Country Link
US (2) US8722101B2 (es)
EP (1) EP1848446B1 (es)
JP (1) JP5060312B2 (es)
KR (1) KR20070107106A (es)
CN (1) CN101155593A (es)
AT (1) ATE445406T1 (es)
AU (1) AU2006212322B2 (es)
BR (1) BRPI0606974A2 (es)
CA (1) CA2597154C (es)
CR (1) CR9300A (es)
CY (1) CY1109685T1 (es)
DE (1) DE502006005100D1 (es)
DK (1) DK1848446T3 (es)
ES (1) ES2333814T3 (es)
HR (1) HRP20100027T1 (es)
IL (1) IL185020A (es)
MX (1) MX2007009588A (es)
NO (1) NO20074536L (es)
PL (1) PL1848446T3 (es)
PT (1) PT1848446E (es)
RU (1) RU2359680C2 (es)
SI (1) SI1848446T1 (es)
TN (1) TNSN07307A1 (es)
UA (1) UA88347C2 (es)
WO (1) WO2006084782A1 (es)
ZA (1) ZA200707716B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
CA2953964A1 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
WO2010108493A1 (en) 2009-03-25 2010-09-30 Pharmacosmos Holding A/S A stable iron oligosaccharide compound
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US11395502B2 (en) * 2012-10-18 2022-07-26 Patrick Monsivais Formulation for iron supplements
WO2014154797A1 (de) * 2013-03-28 2014-10-02 Vifor (International) Ag Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
KR20150078375A (ko) * 2013-12-30 2015-07-08 한화케미칼 주식회사 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
FR3075001B1 (fr) * 2017-12-14 2021-09-10 Tereos Starch & Sweeteners Belgium Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
CN114288320A (zh) * 2021-12-29 2022-04-08 珠海天翼医药技术开发有限公司 一种猪用口服补铁剂及其制备方法
KR20250046064A (ko) 2023-09-26 2025-04-02 주식회사 페라메드 신규한 착화합물, 그를 포함하는 방사선 노출로 인한 조혈 기능 장애 질환의 예방 또는 치료용 약학 조성물 및 그의 제조방법
KR20250110406A (ko) 2024-01-11 2025-07-21 주식회사 페라메드 신규한 착화합물을 이용한 핵산의 증폭 유무를 판별하는 방법
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
DE4421159C1 (de) 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
RU2158595C1 (ru) * 1999-07-07 2000-11-10 Латыпова Лилия Фуатовна Способ лечения иммунопатий при железодефицитной анемии у часто болеющих детей, проживающих в крупном промышленном городе с развитой химической и нефтехимической промышленностью
AU2002220280A1 (en) * 2000-12-07 2002-06-18 Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
JP2005510581A (ja) 2001-04-10 2005-04-21 ダニスコ・ユーエスエー・インコーポレーテッド モノカルボン酸類およびラクトン類を用いた単糖類および二糖類の重合
RU2208440C2 (ru) * 2001-07-20 2003-07-20 Иркутский институт химии им. А.Е. Фаворского СО РАН Средство, обладающее противоанемической и иммуномодуляторной активностью
EP1492821B1 (en) 2002-04-09 2006-08-02 Pharmacosmos Holding A/S Iron dextrin compounds for the treatment of iron deficiency anaemia
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
TNSN07307A1 (en) 2008-12-31
PL1848446T3 (pl) 2010-03-31
IL185020A0 (en) 2007-12-03
AU2006212322B2 (en) 2012-01-19
ES2333814T3 (es) 2010-03-01
JP2008530049A (ja) 2008-08-07
US20080214496A1 (en) 2008-09-04
PT1848446E (pt) 2009-12-21
KR20070107106A (ko) 2007-11-06
RU2359680C2 (ru) 2009-06-27
EP1848446A1 (de) 2007-10-31
UA88347C2 (ru) 2009-10-12
AU2006212322A1 (en) 2006-08-17
US8722101B2 (en) 2014-05-13
BRPI0606974A2 (pt) 2009-07-28
RU2007133509A (ru) 2009-03-20
HRP20100027T1 (hr) 2010-02-28
DK1848446T3 (da) 2010-02-15
ATE445406T1 (de) 2009-10-15
EP1848446B1 (de) 2009-10-14
US20140187514A1 (en) 2014-07-03
CN101155593A (zh) 2008-04-02
NO20074536L (no) 2007-11-05
ZA200707716B (en) 2008-06-25
DE502006005100D1 (de) 2009-11-26
SI1848446T1 (sl) 2010-01-29
CA2597154C (en) 2011-03-15
WO2006084782A1 (de) 2006-08-17
CY1109685T1 (el) 2014-08-13
IL185020A (en) 2013-10-31
CA2597154A1 (en) 2006-08-17
JP5060312B2 (ja) 2012-10-31
MX2007009588A (es) 2007-09-12

Similar Documents

Publication Publication Date Title
CR9300A (es) Uso de compuestos de hierro (iii)
ES2572329A2 (es) Combinacion de al menos dos agentes antivirales de accion directa y ribavirina pero no interferon, para uso en el tratamientodel vhc
BR112012018345A2 (pt) "compostos de heteroarila, bem como composições e usos dos mesmos"
BRPI0813237B8 (pt) composto, método para preparar o composto, medicamento, e, uso do composto
MX2010004576A (es) Derivados de pirimidina novedosos.
WO2010004197A3 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
TW200942524A (en) Novel aminomethyl benzene derivatives
MX2010001849A (es) Depsipeptidos ciclicos.
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA200870421A1 (ru) Димеры производных артемизинина, их получение и их применение в терапии
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
WO2006124861A3 (en) Benzofuran compounds
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200726763A (en) Novel compound
ECSP078024A (es) Inhibidores de la adenilato ciclasa soluble
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble
WO2009008888A8 (en) African swine virus polypeptides as vaccines and its therapeutic use thereof
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
DOP2007000059A (es) Inhibidores de la adenilato ciclasa soluble
DOP2007000060A (es) Inhibidores de la adenilato ciclasa soluble
DK1962822T3 (da) Terapi af maligne neoplasier